|
Name |
gamma-Curcumene
|
Molecular Formula | C15H24 | |
IUPAC Name* |
1-methyl-4-[(2R)-6-methylhept-5-en-2-yl]cyclohexa-1,3-diene
|
|
SMILES |
CC1=CC=C(CC1)[C@H](C)CCC=C(C)C
|
|
InChI |
InChI=1S/C15H24/c1-12(2)6-5-7-14(4)15-10-8-13(3)9-11-15/h6,8,10,14H,5,7,9,11H2,1-4H3/t14-/m1/s1
|
|
InChIKey |
NGIVKZGKEPRIGG-CQSZACIVSA-N
|
|
Synonyms |
gamma-Curcumene; 28976-68-3; T89VH793AF; .gamma.-Curcumene; 1-methyl-4-[(2R)-6-methylhept-5-en-2-yl]cyclohexa-1,3-diene; 1,3-Cyclohexadiene, 1-((1R)-1,5-dimethyl-4-hexen-1-yl)-4-methyl-; 1,3-Cyclohexadiene, 1-(1,5-dimethyl-4-hexenyl)-4-methyl-, (R)-; 1-((1R)-1,5-Dimethyl-4-hexen-1-yl)-4-methyl-1,3-cyclohexadiene; 2-Heptene, 2-methyl-6-(4-methyl-1,3-cyclohexadien-1-yl)-, (R)-(-)-; UNII-T89VH793AF; CHEBI:63696; DTXSID901318194; C20179; Q27132733
|
|
CAS | 28976-68-3 | |
PubChem CID | 12304273 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 204.35 | ALogp: | 4.7 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 15 | QED Weighted: | 0.54 |
Caco-2 Permeability: | -4.548 | MDCK Permeability: | 0.00001300 |
Pgp-inhibitor: | 0.971 | Pgp-substrate: | 0.011 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.283 |
30% Bioavailability (F30%): | 0.222 |
Blood-Brain-Barrier Penetration (BBB): | 0.135 | Plasma Protein Binding (PPB): | 98.61% |
Volume Distribution (VD): | 4.831 | Fu: | 3.30% |
CYP1A2-inhibitor: | 0.834 | CYP1A2-substrate: | 0.577 |
CYP2C19-inhibitor: | 0.289 | CYP2C19-substrate: | 0.942 |
CYP2C9-inhibitor: | 0.245 | CYP2C9-substrate: | 0.768 |
CYP2D6-inhibitor: | 0.699 | CYP2D6-substrate: | 0.781 |
CYP3A4-inhibitor: | 0.104 | CYP3A4-substrate: | 0.456 |
Clearance (CL): | 1.287 | Half-life (T1/2): | 0.409 |
hERG Blockers: | 0.02 | Human Hepatotoxicity (H-HT): | 0.544 |
Drug-inuced Liver Injury (DILI): | 0.04 | AMES Toxicity: | 0.02 |
Rat Oral Acute Toxicity: | 0.017 | Maximum Recommended Daily Dose: | 0.61 |
Skin Sensitization: | 0.948 | Carcinogencity: | 0.281 |
Eye Corrosion: | 0.503 | Eye Irritation: | 0.986 |
Respiratory Toxicity: | 0.249 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000198 | 0.511 | D0M1PQ | 0.396 | ||||
ENC000796 | 0.464 | D03VFL | 0.227 | ||||
ENC000804 | 0.448 | D0W6DG | 0.222 | ||||
ENC003075 | 0.441 | D0S7WX | 0.195 | ||||
ENC001484 | 0.439 | D0O1UZ | 0.182 | ||||
ENC002844 | 0.414 | D06LYG | 0.181 | ||||
ENC002234 | 0.414 | D05XQE | 0.174 | ||||
ENC000963 | 0.388 | D0X0RI | 0.169 | ||||
ENC001455 | 0.355 | D00HZV | 0.169 | ||||
ENC000230 | 0.346 | D0K4MH | 0.167 |